GLAND PHARMA
Quarterly Results Analysis [Mar2026]
GLAND PHARMA Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹1,743 Cr | ₹1,695 Cr | ₹1,487 Cr | ₹1,506 Cr | ₹1,425 Cr | ₹1,384 Cr | ₹1,406 Cr | ₹1,402 Cr |
| Expenses | ₹1,230 Cr | ₹1,260 Cr | ₹1,173 Cr | ₹1,138 Cr | ₹1,077 Cr | ₹1,024 Cr | ₹1,109 Cr | ₹1,137 Cr |
| Operating Income | ₹513 Cr | ₹435 Cr | ₹314 Cr | ₹368 Cr | ₹348 Cr | ₹360 Cr | ₹297 Cr | ₹264 Cr |
| Other Income | ₹111 Cr | ₹63 Cr | ₹84 Cr | ₹58 Cr | ₹44 Cr | ₹58 Cr | ₹60 Cr | ₹51 Cr |
| Interest | ₹10 Cr | ₹4 Cr | ₹8 Cr | ₹11 Cr | ₹7 Cr | ₹23 Cr | ₹6 Cr | ₹6 Cr |
| Depreciation | ₹109 Cr | ₹108 Cr | ₹106 Cr | ₹101 Cr | ₹96 Cr | ₹96 Cr | ₹94 Cr | ₹92 Cr |
| Profit Before Tax | ₹506 Cr | ₹362 Cr | ₹284 Cr | ₹313 Cr | ₹288 Cr | ₹299 Cr | ₹257 Cr | ₹218 Cr |
| Profit After Tax | ₹367 Cr | ₹261 Cr | ₹184 Cr | ₹215 Cr | ₹187 Cr | ₹205 Cr | ₹164 Cr | ₹144 Cr |
| EPS | ₹22.26 | ₹15.87 | ₹11.15 | ₹13.08 | ₹11.32 | ₹12.42 | ₹9.93 | ₹8.73 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GLAND PHARMA | 4.6% | -1.3% | 25.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.6% | 1.2% | 13% |
| DIVIS LABORATORIES | 1.3% | -2.1% | 3.8% |
| TORRENT PHARMACEUTICALS | 1.5% | 0.7% | 37.1% |
| CIPLA | 6.1% | 2.4% | -5.9% |
| DR REDDYS LABORATORIES | 2.6% | -0.4% | -2.1% |
| MANKIND PHARMA | 7% | 2% | 7.9% |
| LUPIN | 4% | 3.4% | 20.4% |
| ZYDUS LIFESCIENCES | 4.8% | 7% | 13.1% |
GLAND PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 2.80 % |
| Y-o-Y | 22.31 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,743 Cr | 2.80 | |
| Dec2025 | ₹1,695 Cr | 14.02 | |
| Sep2025 | ₹1,487 Cr | -1.25 | |
| Jun2025 | ₹1,506 Cr | 5.66 | |
| Mar2025 | ₹1,425 Cr | 2.95 | |
| Dec2024 | ₹1,384 Cr | -1.55 | |
| Sep2024 | ₹1,406 Cr | 0.29 | |
| Jun2024 | ₹1,402 Cr | - | |
GLAND PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 17.97 % |
| Y-o-Y | 47.63 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹513 Cr | 17.97 | |
| Dec2025 | ₹435 Cr | 38.55 | |
| Sep2025 | ₹314 Cr | -14.65 | |
| Jun2025 | ₹368 Cr | 5.83 | |
| Mar2025 | ₹348 Cr | -3.46 | |
| Dec2024 | ₹360 Cr | 21.17 | |
| Sep2024 | ₹297 Cr | 12.35 | |
| Jun2024 | ₹264 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 14.78 % |
| Y-o-Y | 20.71 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 29.44% | 14.78 | |
| Dec2025 | 25.65% | 21.51 | |
| Sep2025 | 21.11% | -13.59 | |
| Jun2025 | 24.43% | 0.16 | |
| Mar2025 | 24.39% | -6.23 | |
| Dec2024 | 26.01% | 23.10 | |
| Sep2024 | 21.13% | 12.04 | |
| Jun2024 | 18.86% | - | |
GLAND PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 40.23 % |
| Y-o-Y | 96.57 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹367 Cr | 40.23 | |
| Dec2025 | ₹261 Cr | 42.35 | |
| Sep2025 | ₹184 Cr | -14.76 | |
| Jun2025 | ₹215 Cr | 15.51 | |
| Mar2025 | ₹187 Cr | -8.87 | |
| Dec2024 | ₹205 Cr | 25.17 | |
| Sep2024 | ₹164 Cr | 13.75 | |
| Jun2024 | ₹144 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 36.45 % |
| Y-o-Y | 60.73 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 21.04 % | 36.45 | |
| Dec2025 | 15.42 % | 24.86 | |
| Sep2025 | 12.35 % | -13.70 | |
| Jun2025 | 14.31 % | 9.32 | |
| Mar2025 | 13.09 % | -11.49 | |
| Dec2024 | 14.79 % | 27.17 | |
| Sep2024 | 11.63 % | 13.35 | |
| Jun2024 | 10.26 % | - | |
GLAND PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 40.26 % |
| Y-o-Y | 96.64 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹22.26 | 40.26 | |
| Dec2025 | ₹15.87 | 42.33 | |
| Sep2025 | ₹11.15 | -14.76 | |
| Jun2025 | ₹13.08 | 15.55 | |
| Mar2025 | ₹11.32 | -8.86 | |
| Dec2024 | ₹12.42 | 25.08 | |
| Sep2024 | ₹9.93 | 13.75 | |
| Jun2024 | ₹8.73 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD